Compare SEQUENT SCIENTIFIC with NGL FINE CHM - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SEQUENT SCIENTIFIC vs NGL FINE CHM - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SEQUENT SCIENTIFIC NGL FINE CHM SEQUENT SCIENTIFIC/
NGL FINE CHM
 
P/E (TTM) x 50.8 24.8 204.9% View Chart
P/BV x 5.6 10.4 54.2% View Chart
Dividend Yield % 0.3 0.1 454.4%  

Financials

 SEQUENT SCIENTIFIC   NGL FINE CHM
EQUITY SHARE DATA
    SEQUENT SCIENTIFIC
Mar-21
NGL FINE CHM
Mar-21
SEQUENT SCIENTIFIC/
NGL FINE CHM
5-Yr Chart
Click to enlarge
High Rs2651,785 14.8%   
Low Rs70255 27.4%   
Sales per share (Unadj.) Rs54.8417.4 13.1%  
Earnings per share (Unadj.) Rs4.291.8 4.6%  
Cash flow per share (Unadj.) Rs6.2105.3 5.9%  
Dividends per share (Unadj.) Rs0.501.75 28.6%  
Avg Dividend yield %0.30.2 174.0%  
Book value per share (Unadj.) Rs29.0249.9 11.6%  
Shares outstanding (eoy) m248.376.18 4,018.9%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x3.12.4 125.0%   
Avg P/E ratio x39.811.1 358.4%  
P/CF ratio (eoy) x26.89.7 276.9%  
Price / Book Value ratio x5.84.1 141.6%  
Dividend payout %11.91.9 623.7%   
Avg Mkt Cap Rs m41,5906,301 660.0%   
No. of employees `000NANA-   
Total wages/salary Rs m1,872281 666.4%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m13,6162,580 527.8%  
Other income Rs m8480 104.3%   
Total revenues Rs m13,7002,660 515.0%   
Gross profit Rs m2,032801 253.7%  
Depreciation Rs m50683 607.1%   
Interest Rs m24422 1,106.3%   
Profit before tax Rs m1,366776 176.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m322209 154.2%   
Profit after tax Rs m1,045567 184.2%  
Gross profit margin %14.931.1 48.1%  
Effective tax rate %23.626.9 87.6%   
Net profit margin %7.722.0 34.9%  
BALANCE SHEET DATA
Current assets Rs m7,6671,245 615.7%   
Current liabilities Rs m5,140421 1,219.7%   
Net working cap to sales %18.631.9 58.1%  
Current ratio x1.53.0 50.5%  
Inventory Days Days3151 61.1%  
Debtors Days Days9353,138,667 0.0%  
Net fixed assets Rs m6,763832 812.5%   
Share capital Rs m49731 1,608.1%   
"Free" reserves Rs m6,7021,514 442.8%   
Net worth Rs m7,1991,545 466.1%   
Long term debt Rs m93761 1,528.4%   
Total assets Rs m14,4302,078 694.5%  
Interest coverage x6.636.2 18.2%   
Debt to equity ratio x0.10 327.9%  
Sales to assets ratio x0.91.2 76.0%   
Return on assets %8.928.4 31.5%  
Return on equity %14.536.7 39.5%  
Return on capital %19.849.7 39.8%  
Exports to sales %075.5 0.0%   
Imports to sales %09.7 0.0%   
Exports (fob) Rs mNA1,947 0.0%   
Imports (cif) Rs mNA251 0.0%   
Fx inflow Rs m6861,977 34.7%   
Fx outflow Rs m281281 100.0%   
Net fx Rs m4051,696 23.9%   
CASH FLOW
From Operations Rs m1,148274 419.5%  
From Investments Rs m96-246 -39.3%  
From Financial Activity Rs m-1,388-11 12,835.7%  
Net Cashflow Rs m-14417 -842.3%  

Share Holding

Indian Promoters % 0.0 73.8 -  
Foreign collaborators % 53.0 0.0 -  
Indian inst/Mut Fund % 8.6 0.0 -  
FIIs % 6.4 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 47.0 26.2 179.4%  
Shareholders   167,812 15,695 1,069.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SEQUENT SCIENTIFIC With:   SUN PHARMA    LUPIN    CIPLA    AUROBINDO PHARMA    DR. REDDYS LAB    



Today's Market

5 Reasons Why Sensex Crashed 1,546 Points Today(Closing)

Indian share markets witnessed heavy selling pressure today and ended deep in the red. The sell-off continued for the fifth straight session today with benchmark indices losing nearly 3% each.

Related Views on News

NGL FINE CHM 2020-21 Annual Report Analysis (Annual Result Update)

Nov 8, 2021 | Updated on Nov 8, 2021

Here's an analysis of the annual report of NGL FINE CHM for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of NGL FINE CHM. Also includes updates on the valuation of NGL FINE CHM.

SEQUENT SCIENTIFIC 2020-21 Annual Report Analysis (Annual Result Update)

Oct 25, 2021 | Updated on Oct 25, 2021

Here's an analysis of the annual report of SEQUENT SCIENTIFIC for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of SEQUENT SCIENTIFIC. Also includes updates on the valuation of SEQUENT SCIENTIFIC.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

More Views on News

Most Popular

Tata Steel vs SAIL: Which Stock is Better?(Views On News)

Jan 13, 2022

With government initiatives set to boost the steel sector, find out who has a better chance of coming out on top.

Watch Out for these 4 Indian Companies Betting Big on EV Supply Chain(Views On News)

Jan 11, 2022

The upside in supply chain players could be huge but a delay in the transition to EVs, or any policy related hiccups could end the momentum.

These 5 Penny Stocks are Held by Rakesh Jhunjhunwala. Worth a Look?(Views On News)

Jan 18, 2022

Rakesh Jhunjhunwala is holding these penny stocks in his portfolio for several years now.

Tech Mahindra's CTC Acquisition: Too Expensive?(Views On News)

Jan 18, 2022

Tech Mahindra's acquisition of European IT-company fails to excite investors.

Time to Buy Energy Stocks(Fast Profits Daily)

Jan 14, 2022

Energy is a sector that looks set to take off. It's time to get in.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SEQUENT SCIENTIFIC SHARE PRICE


Jan 24, 2022 03:36 PM

TRACK SEQUENT SCIENTIFIC

  • Track your investment in SEQUENT SCIENTIFIC with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SEQUENT SCIENTIFIC

SEQUENT SCIENTIFIC 5-YR ANALYSIS

COMPARE SEQUENT SCIENTIFIC WITH

MARKET STATS